go back

New Mexico rates for HCPCS Q2056

Ciltacabtagene autoleucel, up to 100 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $1,698,244 · 10th–90th $645,654–$3,981,0720%10%10th90th$1,698,244Professionalmedian $588,844 · 10th–90th $588,844–$912,0110%50%90th$588,844$100.0K$200.0K$500.0K$1.0M$2.0M$5.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$645,654.23 / $912,010.84 / $2,041,737.94
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$588,843.66 / $588,843.66 / $912,010.84
BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$831,763.77 / $2,818,382.93 / $4,570,881.90
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$549,540.87 / $549,540.87 / $912,010.84
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$588,843.66 / $588,843.66 / $588,843.66